No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 4159-4161

  Lundstig, Annika ^a,b   Dejmek, Annika ^b   Eklund, Carina ^a   Filinic, Ivo ^b   Dillner, Joakim ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Mesothelioma tissues; Quantitative PCR; SV40; Tumor virology

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; INCIDENCE; MALE; MESOTHELIOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; SWEDEN; VIRUS DETECTION;

EID: 37549014837     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sweet BH and Hilleman MR: The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med 105: 420-427, 1960.
2. Shah K and Nathanson N: Human exposure to SV40: review and comment. Am J Epidemiol 103(1): 1-12, 1976.
3. Butel JS and Lednicky JA: Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91(2): 119-134, 1999.
4. Minor P et al: Studies of neutralising antibodies to SV40 in human sera. J Med Virol 70(3): 490-495, 2003.
5. Vilchez RA, Kozinetz CA and Butel JS: Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol 4(3): 188-191, 2003.
6. Hoogsteden HC et al: Malignant pleural mesothelioma. Crit Rev Oncol Hematol 25(2): 97-126, 1997.
7. Cristaudo A et al: SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study. Cancer Res 65(8): 3049-3052, 2005.
8. Bolognesi C et al: A molecular epidemiology case control study on pleural malignant mesothelioma. Cancer Epidemiol Biomarkers Prev 14(7): 1741-1746, 2005.
9. Shah KV: SV40 and human cancer: a review of recent data. Int J Cancer 120(2): 215-223, 2007.
10. Brockstedt U et al: An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 114(2): 203-209, 2000.
11. Forslund O, Nordin P and Hansson BG: Mucosal human papillomavirus types in squamous cell carcinomas of the uterine cervix and subsequently on fingers. Br J Dermatol 142(6): 1148-1153, 2000.
12. Forslund O et al: High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol 123(2): 388-394, 2004.
13. Hazard K et al: Subtype HPV38b [FA125] demonstrates heterogeneity of human papillomavirus type 38. Int J Cancer, 2006.
14. Saiki RK et al: Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230(4732): 1350-1354, 1985.
15. Lundstig A et al: Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles. J Gen Virol 86(Pt 6): 1703-1708, 2005.
16. Heid CA et al: Real time quantitative PCR. Genome Res 6(10): 986-994, 1996.
17. Tedeschi R et al: Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol 39(12): 4269-4273, 2001.
18. Carbone M et al: Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9(6): 1781-1790, 1994.
19. Jin, M et al: Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan. J Med Virol 74(4): 668-676, 2004.
20. Kroczynska B et al: Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci USA 103(38): 14128-14133, 2006.
21. Robinson C et al: A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. Cancer Res 66(22): 10786-10794, 2006.
22. Manfredi JJ et al: Evidence against a role for SV40 in human mesothelioma. Cancer Res 65(7): 2602-2609, 2005.
23. Lopez-Rios F et al: Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 364(9440): 1157-1166, 2004.
24. Olin P and Giesecke J: Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993. Dev Biol Stand 94: 227-233, 1998.
25. Priftakis P et al: Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas. Anticancer Res 22(3): 1357-1360, 2002.